AI is learning to design life-saving drugs from scratch
Pharma and tech giants like Eli Lilly and Nvidia see generative AI taking over drug discovery within a few years. By treating molecules and proteins like words in a sentence, AI can generate candidates in minutes that would take labs a year to synthesize, cutting research timelines from years to months. The real bottleneck remains human clinical trials.